Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

Female lung transplant recipients more likely to suffer from primary graft dysfunction

Female lung transplant recipients are significantly more likely to suffer from a type of injury to the transplanted lung called primary graft dysfunction than male lung transplant patients, according to a study presented at the American Thoracic Society International Conference.

25 May 2005

Market forces alone are not sufficient to produce new drugs needed for children with cancer

Faced with "a near absence of research in pediatric cancer drug discovery," the IOM report recommends forming new public-private partnerships among government, industry, researchers, advocacy groups and other parties to lead research and development.

23 May 2005

EraGen Biosciences and Bayer announce agreements for new cystic fibrosis (CF) assay

EraGen Biosciences, a rapidly growing molecular diagnostics company and Bayer HealthCare LLC, Diagnostics Division, announced today that EraGen has licensed its patented MultiCode-PLx® System to Bayer HealthCare in an exclusive worldwide agreement for Cystic Fibrosis.

18 May 2005

First DNA-based blood test to help detect cystic fibrosis

The Food and Drug Administration (FDA) has approved the first DNA-based blood test to help detect cystic fibrosis. The Tag-It Cystic Fibrosis Kit directly analyzes human DNA to find genetic variations indicative of the disease. The test will be used to help diagnose cystic fibrosis in children and to identify adults who are "carriers" of the gene variations.

10 May 2005

Baby gene tests safety should be checked

Experts are warning that the long-term safety of screening embryos for genetic diseases is going unchecked.

26 Apr 2005

New method for the study of ion channel gating kinetics

An ion channel is a protein pore that lets ions (charged atoms such as calcium) pass through a cell's membrane. The method fits data to a new class of models, called manifest interconductance rank (MIR) models, which will give researchers a better understanding of the mechanisms by which ion channels open and close.

19 Apr 2005

Why different tissues in the human body vary in their susceptibility to "amyloid" diseases

Researchers at The Scripps Research Institute are reporting the results of a recent study that addresses why different tissues in the human body vary in their susceptibility to "amyloid" diseases, which include Alzheimer's disease and a cluster of ailments called the familial amyloidoses.

7 Apr 2005

Novel strategy to create a genetic vaccine against P. aeruginosa

Pseudomonas aeruginosa is a bacterium that can cause respiratory tract infections, which can be life threatening in patients who have cystic fibrosis. It is therefore important to develop a vaccine against this pathogen.

3 Apr 2005

Mountaineering doctors hike medicine to new heights with Xtreme Everest

Doctors working at the edge of extreme are set to climb the world’s tallest mountain to look death in the face – and take its pulse. The medical research team will make the first ever measurements of blood oxygen in the ‘death zone’, at altitudes above 8,000 metres where the human body has struggled - and frequently failed - to survive.

16 Mar 2005

Medical tests in the privacy of your own home

A San Francisco-based testing company is currently offering genetic testing, for a predisposition to cystic fibrosis, blood clotting, iron overload and a heightened risk for lung and liver diseases; prices ranging from $199 to $380.

7 Mar 2005

U.S. cancer researchers launch first American-Israeli cancer conference

Leading cancer researchers from Baltimore, Miami and New Jersey have organized the first Joint American-Israeli Conference on Cancer. The meeting, scheduled for March 16 through 18 in Jerusalem, seeks to foster collaboration among physicians and scientists in the two countries.

1 Mar 2005

Beginning of new wave - first generation to turn 18 since technology and treatments have allowed them to survive to adulthood

More than half a million children with special health-care needs will turn 18 this year, the first generation to reach adulthood since sweeping medical advances ensured an unprecedented number would survive congenital conditions that until recently would have killed them.

27 Feb 2005

Safer approach to treating children with cystic fibrosis

Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week’s issue of The Lancet.

10 Feb 2005

Potential treatments for neurofibromatosis

Scientists at the Indiana University School of Medicine are closing in on potential treatments for neurofibromatosis, a genetic disease that afflicts 100,000 Americans with nerve tissue tumors, some of which become cancerous.

3 Feb 2005

Patient safety measures work at children’s hospitals

In recent years, children's hospitals have joined in the national push to improve patient safety and avoid preventable problems. But it has been hard to measure progress, because of uncertainty about whether standard patient safety measurement tools apply to their patients, who are younger, smaller and on average sicker than those at other hospitals.

4 Jan 2005

£2.5 million to support further research into gene therapy for cystic fibrosis

The funding commitment was made in the Genetics White Paper, 'Our Inheritance, Our Future: Realising the potential of genetics in the NHS' and will help to ensure that those with cystic fibrosis benefit as soon as possible from the latest advances in genetic knowledge and technologies.

4 Jan 2005

Australia leads the way in new screening technology for babies

Australia is one of the first countries in the world to implement new screening technology across all States that will help detect an increased number of diseases in newborns.

21 Dec 2004

Trimming fat overcomes one of the major obstacles to drug design

Biochemists at Ohio State University and their colleagues have overcome one of the major obstacles to drug design, by trimming some of the fat from a molecular sponge that scientists use to study proteins.

8 Dec 2004

Research shows that even bacteria don't put their eggs in one basket

Diversification helps reduce overall risk by putting your eggs in more than one basket and is a strategy that strengthens groups of all kinds -- from forests challenged with environmental stress to stock market portfolios in uncertain times. Findings from University of Iowa researchers show that even bacteria have learned this important lesson.

16 Nov 2004

Discovery of new compounds that may treat mucus build-up associated with cystic fibrosis

Preliminary studies show these compounds improve the flow of mucus through the respiratory tract, allowing airways to clear more quickly and efficiently.

14 Nov 2004